LECTURE 11: DRUG DEVELOPMENT AND SCHEDULING Flashcards
From idea to regulated product
Drug development -> Drug testing -> Drug registration and scheduling
drug development
very expensive, long winded process undertaken by the drug company
drug testing
huge financial investments to get drug to market
testing is done under the supervision of the body who will register the drug
who registers drugs
therapeutic goods administration (TGA)
scheduling of poisons depends on
- the risk of harm when used appropriately and inappropriately
- the risk of addiction e.g. heroin
schedule 0
unscheduled products
paracetamol ≤ 500mg in packets containing ≤ 20 tablets/capsules
schedule 1
“not in use”
no examples
schedule 2
pharmacy medicine
aspirin (≤325mg, ≤500mg or ≤625mg*),
schedule 3
pharmacist only medicine
ibuprofen (≤400mg),
schedule 4
prescription only
codeine (≤30mg),
schedule 5
caution - low potential for harm
ethylene glycol (radiator fluid)
schedule 6
poison - moderate harm
arsenic (ant bait)
schedule 7
dangerous poisons - high harm
strychnine
schedule 8
controlled drug - pharmacist
ketamine
S8 restrictions
ingoings = outgoings
every dose is signed off by a veterinarian, doctor or dentist
inventory taken at least once a month
up to date and ready for unannounced spot audit by WA Health Department